These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 286092)

  • 1. Cancer patients' plasma lacking lymphocytic cortisol metabolism-enhancing factor in comparison with plasma of healthy donors.
    Klein A; Kaufman H; Hoogervorst-Spalter H; Arie R; Mannheimer S; Fleminger R; Joshua H
    J Natl Cancer Inst; 1979 May; 62(5):1159-61. PubMed ID: 286092
    [No Abstract]   [Full Text] [Related]  

  • 2. First isolation step of a plasma factor which enhances lymphocytic cortisol metabolism and which is reduced in cancer patients.
    Klein A; Stern M; Kaufmann H; Spalter E; Meyerson E; Hildesheim J
    Cancer Detect Prev; 1983; 6(1-2):107-10. PubMed ID: 6883372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of cancer in patients by reduced lymphocytic cortisol metabolism-enhancing effect.
    Klein A; Kaufman H; Arie R; Hoogervorst-Spalter H; Semach E; Barkan A; Martfel J; Servadio C
    J Natl Cancer Inst; 1980 Nov; 65(5):857-61. PubMed ID: 6933254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer and dysplasia of cervix in relation to reduced lymphocytic cortisol metabolism-enhancing effect.
    Klein A; Storch B; Beckerman A; Meyerson E; Colev S; Kaufmann H; Schachter A
    J Natl Cancer Inst; 1984 Mar; 72(3):605-7. PubMed ID: 6583443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basal cell carcinomas, gastrointestinal carcinomas, and ulcerative colitis in relation to the disappearance of a plasma factor.
    Klein A; Storch B; Meyerson E; Kadish U; Kaufmann H; Feuerman EJ
    Cancer Detect Prev; 1983; 6(6):527-30. PubMed ID: 6661742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sera of patients with cancer or cirrhosis and of newborns exhibiting inhibitory effects on the metabolism of cortisol by lymphocytes.
    Klein A; Archer SM; Malkin A
    J Natl Cancer Inst; 1986 Jul; 77(1):29-31. PubMed ID: 3459922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of tumor removal on the presence of lymphocytic cortisol metabolism-enhancing factor in plasma of cancer patients.
    Barkan A; Barkan E; Hoogervorst-Spalter H; Kaufman H; Klein A
    J Natl Cancer Inst; 1980 Jun; 64(6):1333-5. PubMed ID: 6929371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transport of cortisol by cultured chronic lymphocytic leukemic lymphocytes.
    Amaral L; Samuels AJ; Werthamer S
    Experientia; 1971 May; 27(5):511-2. PubMed ID: 5132576
    [No Abstract]   [Full Text] [Related]  

  • 9. Liver diseases and cancer associated with lack of lymphocytic cortisol metabolism enhancing factor.
    Klein A; Barkan E; Barkan A; Hoogervorst-Spalter H; Arie R; Kaufmann H
    Metabolism; 1980 Aug; 29(8):780-6. PubMed ID: 7402079
    [No Abstract]   [Full Text] [Related]  

  • 10. The influence of homologous plasma and fetal calf serum on human lymphocytic cortisol metabolism.
    Klein A; Kaufmann H; Arie R; Hoogervorst-Spalter HG; Joshua H
    Experientia; 1979 Jan; 35(1):114-5. PubMed ID: 421777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary cortisol resistance associated with a thermolabile glucocorticoid receptor in a patient with fatigue as the only symptom.
    Brönnegård M; Werner S; Gustafsson JA
    J Clin Invest; 1986 Nov; 78(5):1270-8. PubMed ID: 3771797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortisol metabolism in lymphocytes from cancer-bearing patients.
    Klein A; Kaufmann H; Mannheimer S; Joshua H
    Metabolism; 1978 Jun; 27(6):731-6. PubMed ID: 651657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cortisol catabolism by lymphocytes of patients with systemic lupus erythematosus and rheumatoid arthritis.
    Klein A; Buskila D; Gladman D; Bruser B; Malkin A
    J Rheumatol; 1990 Jan; 17(1):30-3. PubMed ID: 2313669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cortisol content in the blood plasma in lung cancer].
    Uspenskaia LP; Medvedev VN; Firsova PP
    Vopr Onkol; 1978; 24(10):58-61. PubMed ID: 716319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers of depression in cancer patients.
    Jehn CF; Kuehnhardt D; Bartholomae A; Pfeiffer S; Krebs M; Regierer AC; Schmid P; Possinger K; Flath BC
    Cancer; 2006 Dec; 107(11):2723-9. PubMed ID: 17036362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cortisol response to an acute injection of IL-2 in healthy subjects and cancer patients: a first immunoneuroendocrine standardized clinical test to explore the interactions between immune and neuroendocrine systems.
    Lissoni P; Messina G; Brivio F; Rovelli F; Di Fede G; Mainini E; Veronese E
    J Biol Regul Homeost Agents; 2005; 19(3-4):141-4. PubMed ID: 16602629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered cortisol metabolism in cells cultured from trabecular meshwork specimens obtained from patients with primary open-angle glaucoma.
    Southren AL; Gordon GG; Munnangi PR; Vittek J; Schwartz J; Monder C; Dunn MW; Weinstein BI
    Invest Ophthalmol Vis Sci; 1983 Oct; 24(10):1413-7. PubMed ID: 6618802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACTH and cortisol plasma levels in cancer patients treated with medroxyprogesterone acetate at high dosages.
    Papaleo C; Carella C; Zito GA; Figlia A; Capuano F; Amato G
    Chemioterapia; 1984 Aug; 3(4):220-2. PubMed ID: 6099752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does endogenous cortisol play a role in the development of cancer?
    Klein A
    Med Hypotheses; 1982 Feb; 8(2):163-71. PubMed ID: 6979671
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of glycyrrhizin on cortisol metabolism in humans.
    Soma R; Ikeda M; Morise T; Miyamori I; Takeda R
    Endocr Regul; 1994 Mar; 28(1):31-4. PubMed ID: 7949011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.